ArticleFrontiers in pharmacology2026

Real-world risk assessment of combined cilostazol-rosuvastatin: a retrospective cohort study using Korean electronic health records.

Woo-Young Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.